Restaurant Brands Asia Limited (‘Company’) has announced a significant strategic move through its Borrowings, Investments, Loans and Finance Committee. On April 24, 2026, the committee approved a further investment in its Indonesian subsidiary, PT Sari Burger Indonesia (‘BK Indonesia’). The investment involves the subscription of 35,000 redeemable cumulative non-convertible preference shares with a nominal value of IDR 1,000,000 each. This aggregate investment of IDR 35,000,000,000 (Thirty-Five Billion Indonesian Rupiah) is intended to support the business requirements of the Indonesian operations.

This capital infusion is a related party transaction aimed at strengthening the Company’s presence in the Southeast Asian market, where BK Indonesia operates 133 outlets as of March 31, 2026. The transaction is expected to be completed within two months and will be conducted at arm’s length. Notably, the acquisition of these preference shares does not impact the existing equity shareholding or voting rights within BK Indonesia. This move follows a period where BK Indonesia reported a standalone turnover of IDR 965,168.88 million for the financial year ending March 31, 2025.

Restaurant Brands Asia, formerly known as Burger King India Limited, is a major player in the quick-service restaurant (QSR) sector, primarily managing the “Burger King” brand in India and Indonesia. Throughout 2025 and early 2026, the company has remained active in corporate restructuring and capital raising, including the closure of a Qualified Institutions Placement (QIP) at an issue price of ₹60 per share in March 2026. Recent operational updates highlight a focus on cost-cutting measures, such as the installation of solar panels to reduce expenses. Additionally, while there was speculation regarding investment from Ajanta Pharma’s promoters, the company clarified in early 2026 that no such stake acquisition was considered.

The company’s financial performance for the quarter ended December 31, 2025, showed a robust revenue growth of 17.17% year-on-year, reaching ₹5,800 million compared to ₹4,950 million in the previous year’s corresponding quarter. During this period, the net loss significantly narrowed to ₹70 million from ₹186.3 million. The company is supported by prominent institutional investors, including the HDFC Flexi Cap Fund, which held a 9.57% stake as of March 2026, and ICICI Prudential Life Insurance Company, holding 7.04%. Other notable investors include Rajasthan Global Securities and various Vanguard index funds.